LMW Heparin MMX (low molecular weight heparin) / Cosmo Pharma - LARVOL DELTA

PO.MCB01.05 - Tumor-Stroma and Cell-Cell interactions (AACR 2018) - No abstract available.

Oncology

Salix Announces early termination of HSR waiting period for pending transaction (Salix Press Release) - "Salix...announced that it has received notice of the early termination of the waiting period for U.S. antitrust review...Completion of the transaction remains subject to approval by Salix’s stockholders and certain other closing conditions."

Anticipated M & A • Inflammatory Bowel Disease

Salix calls off inversion deal amid U.S. government crackdown (Reuters) - "Salix Pharmaceuticals ...citing a 'changed political environment,' said on Friday it had scrapped a deal with Italy's Cosmo Pharmaceuticals...that would have allowed it to shift its tax base from the United States to Europe....Shares of Salix were up 5 percent at $158.50 in premarket trading, reflecting investors' hopes that calling off an inversion makes a sale of the company more likely."

M&A • Inflammatory Bowel Disease